Advertisement

The Scientist

» reagents, disease/medicine and evolution

Most Recent

image: Oxytocin for Autism?

Oxytocin for Autism?

By | January 21, 2015

Scientists find that the hormone improves sociability in a mouse model of autism.

4 Comments

image: Fraction of SNPs Can Affect Fitness

Fraction of SNPs Can Affect Fitness

By | January 21, 2015

A point mutation analysis of the entire human genome finds that alterations to as many as 7.5 percent of nucleotides may have contributed to humans’ evolutionary split from chimpanzees.

1 Comment

image: Tracking Tuberculosis Over Time

Tracking Tuberculosis Over Time

By | January 19, 2015

Genomic analysis of a multidrug-resistant lineage pinpoints historical correlations with human events.

0 Comments

image: Inflammation Overdrive

Inflammation Overdrive

By | January 15, 2015

Experimental vaccines that specifically boost T helper cells lead to immunopathology and death in mice.

2 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Reassessing One Really Old Fish

Reassessing One Really Old Fish

By | January 13, 2015

New analysis of an ancient specimen prompts a rethink of fish forebears.

1 Comment

image: Ebola Update

Ebola Update

By | January 12, 2015

Researchers gear up for efficacy trials of experimental Ebola vaccines in Africa.

0 Comments

image: Growing Human Guts in Mice

Growing Human Guts in Mice

By | January 12, 2015

Researchers make more progress toward growing human intestines in mice, paving the way for better models of intestinal function and failure.

0 Comments

image: The Benefits of Being a “Bearded Lady”

The Benefits of Being a “Bearded Lady”

By | January 8, 2015

A study of female eastern fence lizards that bear a distinctly male trait yields tantalizing clues about the tradeoffs involved in blurring the lines of sexual dimorphism.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
System Biosciences
System Biosciences